Skip to main content
Loading…

Search

There are 15,358 results relating to "Medicin Viagra-m"

Order by |

Refine your search

Select from the available filters to refine your search


Available filters:

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].

Questions and Answers Date answered: 12 November 2003

S2W-03473

To ask the Scottish Executive which drugs have been withdrawn from use for the treatment of people under 18 in each of the last three years. The safety of medicines is areserved matter and is the responsibility of the Medicines and Healthcare ProductsRegulatory Agency.The agency has advised that theCommittee on Safety of Medicines recently issued advice that the antidepressantdrugs paroxetine (Seroxat) and venlafaxine (Efexor) should not be used inchildren and adolescents aged less than 18 years of age with depressiveillness.
Questions and Answers Date answered: 23 July 2003

S2W-01175

Wyeth Pharmaceuticals are currently completing post-marketing studies for ReFacto. As with all new medicines, the safety of ReFacto is also routinely monitored by the Medicines and Healthcare products Agency, the Committee on Safety of Medicines and by European regulatory auth...
Questions and Answers Date answered: 23 July 2003

S2W-01175

Wyeth Pharmaceuticals are currently completing post-marketing studies for ReFacto. As with all new medicines, the safety of ReFacto is also routinely monitored by the Medicines and Healthcare products Agency, the Committee on Safety of Medicines and by European regulatory auth...
Questions and Answers Date answered: 5 November 2002

S1W-30500

To ask the Scottish Executive whether there are no long-term risks to children from increased prescribing of Ritalin. As with all medicines, the safety of Ritalin is continually monitored by the Medicines Control Agency and the Committee on Safety of Medicines, an independent...
Questions and Answers Date answered: 2 July 2002

S1W-26868

The Right Medicine: A Strategy for Pharmaceutical Care in Scotland commits the Scottish Executive Health Department to explore the creation of a combined community and hospital medicines utilisation database by July 2003.
Questions and Answers Date answered: 7 December 2001

S1W-20357

To ask the Scottish Executive when the proposed NHS Boards will put agreements in place with education authorities relating to the administration of medicines in schools. Guidance on the administration of medicine in schools was issued on 4 September.
Official Report Meeting date: 2 November 1999

Procedures Committee, 02 Nov 1999

Mid-week Activities Item 8 appears on the agenda as "MSPs' movements mid-week"—despite instructions to the contrary, the clerks have removed the capital M from the word "movements". I am impressed that there have been 129 replies.
Questions and Answers Date answered: 1 March 2005

S2W-14033

These loans were accounted foron a cash accounting basis until 2000-01, and therefore there were no loancosts (apart from SLC administration costs – see below) to the ScottishExecutive or its predecessor, The Scottish Office.Thechange in accounting treatment from Cash Accounting to Resource Accounting as describedin the answer to S2W-14052, answered on 25 February 2005, introduced a cost for all student loan advances.Resourceaccounts giving the cost of student loans for students domiciled in Scotland areavailable from 1999-2000, and these can be found on the Scottish Executivewebsite at:www.scotland.gov.uk/publications.The cost to the ScottishExecutive of the Student Loans Company since 1999-2000 is as follows:- Year *£m...
Questions and Answers Date answered: 22 February 2002

S1W-22884

To ask the Scottish Executive whether it will list the publication dates for all up-dated data previously available in Chapter M, Hospital and Clinical Activity, of Scottish Health Statistics 2000.
Questions and Answers Date answered: 20 July 2004

S2W-09267

The Scottish Executive is in regular contact with the UK Government on a wide range of issues, including pharmaceuticals. The regulation of medicines is a reserved matter and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].